Rockefeller Capital Management’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.88K Sell
1,861
-479
-20% -$2.52K ﹤0.01% 4305
2026
Q2
$13.6K Buy
2,340
+74
+3% +$491 ﹤0.01% 3890
2026
Q1
$16.4K Buy
2,266
+1,405
+163% +$18.3K ﹤0.01% 3787
2025
Q4
$14.6K Buy
+861
New +$8.75K ﹤0.01% 3647
2021
Q1
– Sell
-82
Closed – – 3410
2020
Q4
$0 Buy
+82
New – ﹤0.01% 3023

Other funds holding WVE

Rockefeller Capital Management's WVE Position: Q3 2026 in Review

Rockefeller Capital Management reduced its Wave Life Sciences (WVE) stake by 20% in Q3 2026, selling an estimated $2.52K and leaving 1,861 shares worth $6.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4305.

Rockefeller Capital Management first reported a position in WVE in Q4 2020 and has held it in 5 quarters since. The position peaked at $16.4K in Q1 2026. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • Rockefeller Capital Management held 1,861 shares of Wave Life Sciences worth $6.88K as of Q3 2026.
  • Rockefeller Capital Management sold 479 Wave Life Sciences shares in Q3 2026, an estimated $2.52K.
  • Wave Life Sciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4305 holding.
  • Rockefeller Capital Management first reported a position in Wave Life Sciences in Q4 2020 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Wave Life Sciences position peaked at $16.4K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.